Clinical Trial Update: Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing fluticasone/salmeterol versus double the dose fluticasone in patients with mild to moderate asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone (fluticasone propionate)
• Fluticasone/Salmeterol (fluticasone/salmeterol)

Snippet

Sponsor: University of Dundee | Conditions: Asthma | Phase 4 | Status: COMPLETED